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Epileptogenic mechanisms in focal cortical dysplasia
(FCD) remain elusive, as no animal models faithfully
recapitulate FCD seizures, which have distinct electro-
graphic features and a wide range of semiologies. Given
that DEPDC5 plays significant roles in focal epilepsies
with FCD, we used in utero electroporation with clus-
tered regularly interspaced short palindromic repeats
gene deletion to create focal somatic Depdc5 deletion
in the rat embryonic brain. Animals developed sponta-
neous seizures with focal pathological and electroclinical
features highly clinically relevant to FCD IIA, paving the
way toward understanding its pathogenesis and devel-
oping mechanistic-based therapies.
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Focal cortical dysplasia (FCD) is a common cause ofrefractory focal epilepsies (FEs). As the most common
underlying pathology in children with refractory FEs, it
accounted for 26.8% of those cases in a series of approxi-
mately 2,600 specimens of brain tissue obtained during
epilepsy surgery.1 FCD has been classified into several
subtypes and entities on the basis of histopathology. In
particular, FCD II is an isolated lesion characterized by
disrupted cytoarchitecture including dysmorphic neurons
without (FCD IIA) or with balloon cells (FCD IIB).1,2
Although FCD II is firmly linked to aberrant MTOR sig-
naling pathways,3 a major challenge in understanding its
epileptogenesis and intractability is to develop animal
models that recapitulate its genetics, pathology, and elec-
troclinical expression. For example, transgenic rodent,
antimitotic agent, and irradiation models lack a focal
lesion. Freeze lesions produce circumscribed lesions but
fail to capture its genetics and pathologies. Recently, focal
pathology was replicated in mouse models using in utero
electroporation (IUE) to focally knockdown the mTOR
inhibitor Tsc1/2 or overexpress mutant mTOR activators.4
However, a fundamental impediment to clinical transla-
tion is that none of these models had focal electrographic
signatures of human FCD seizures such as paroxysmal fast
activity (PFA) 5 or fingerprints for the epileptogenic zone
including low-voltage fast activity (LVFA).6 Whereas
nearly all patients develop seizures with various semiol-
ogies, these FCD animals only displayed generalized
tonic-clonic seizures (GTCs), and a significant number of
them did not develop spontaneous seizures.7
The focal lesion seen in FCD II has led to the hypothe-
sis that somatic mosaic mutations are the underlying genetic
mechanism. Recent work has identified somatic activating
mutations in MTOR itself, genes encoding positive regulators
ofMTOR, and new genes as negative regulators ofMTOR via
germline loss-of-function (LoF) mutation coupled to
demonstrated or inferred somatic loss of the second allele.8
Germline or somatic DEPDC5mutations are increasingly rec-
ognized as the common cause of familial or sporadic FEs
including monogenic entities such as familial focal epilepsy
with variable foci, autosomal dominant nocturnal frontal lobe
epilepsy, and familial temporal lobe epilepsy.9 In addition to
its role in magnetic resonance imaging (MRI)-negative FEs,
DEPDC5 has also been associated with epileptogenic struc-
tural brain malformations, from FCD to large cortical malfor-
mations, such as hemimegalencephaly.8 DEPDC5 is part of a
complex named GAP activity toward RAGs complex
1 (GATOR1), together with the proteins NPRL2 and
NPRL3. As a key member of the amino acid sensing machin-
ery, GATOR1 functions independently of TSC1/TSC2 sig-
naling and directly inhibits mTORC1 recruitment to
lysosomal membranes.10 However, no DEPDC5-related FEs
animal model exists, and all Depdc5 transgenic animals
reported to date failed to develop spontaneous seizures. All
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homozygous knockout animals died embryonically, whereas
heterozygous knockouts showed either no or subtle patholo-
gies.11 Although a neuron-specific Depdc5 conditional knock-
out mouse survived to adulthood with severe neurological
phenotypes, spontaneous focal electroclinical seizures were
not recorded.11 Given its significant role in FEs and unique
function in MTOR pathway, we performed IUE with clus-
tered regularly interspaced short palindromic repeats
(CRISPR) gene editing (CRISPR-IUE) on rat brains at
embryonic day (E) 13 to E14 to introduce a focal region with
somatic Depdc5 deletion and generated animals with patho-
logical and electroclinical expression highly similar to human
FCD IIA.
Materials and Methods
Plasmids, IUE, and Animals
Two Depdc5 guide RNAs (gRNAs) were designed using an online
program (http://crispr.mit.edu) as previously described, and sub-
cloned into the PX330 vector (plasmid 42230; Addgene, Cam-
bridge, MA).12 Depdc5B was designed to target exon 12: 50-
GGTGGTGCAGAACGAGAGAA -30, and Depdc5M was designed
to target exon 8: 50- GTTCCGTTCTACGTCGGCTA-30. The
faithfulness scores were 95 and 98, respectively. pCAG–green fluo-
rescence protein (GFP), piggyBac donor plasmid (PBCAG-eGFP),
and helper plasmid encoding piggyBac transposase (PBCAG-PBase)
were obtained from Dr Joseph LoTurco (University of Connecti-
cut).13 IUE was performed on rats (Sprague-Dawley; Charles River,
Wilmington, MA) as previously described.12 The final
FIGURE 1:
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concentrations used for transfections were 0.5 μg/μl for eGFP and
1.5 μg/μl for Depdc5 CRISPR gRNA/Cas9. To track the entire line-
age of transfected neural progenitors, PBCAG-eGFP (0.5 μg/μl) and
pCAG-PBase (1 μg/μl) were coelectroporated with Depdc5 CRISPR
gRNA/Cas9. pCAG-eCas9-T2A-GFP-U6-gRNA plasmid (a gift
from Jizhong Zou; Addgene plasmid # 79145) was used at 1.5 μg/
μl. All animal studies were approved by the institutional animal care
and use committee of the University of Michigan.
Next Generation Sequencing
To estimate the rate of somatic Depdc5 LoF mosaicism in the
cortex, Depdc5 CRIPSR-IUE–transfected cortex was resected
under the fluorescent dissection microscope. Targeted genomic
areas flanking gRNA binding sites were polymerase chain reac-
tion (PCR)-amplified using Platinum High Fidelity Taq DNA
polymerase (11304-011; Invitrogen, Carlsbad, CA). PCR prod-
ucts were sent for deep sequencing to the Center for Computa-
tional and Integrative Biology, Massachusetts General Hospital,
Harvard. Primers used for targeted sequencing were forward 50




To determine if rats that underwent Depdc5 CRISPR-IUE
exhibit electroclinical seizures and interictal epileptiform dis-
charges (IEDs), we monitored animals with continuous video-
electroencephalography (EEG). Rats were implanted with 4 epi-
dural screw electrodes at P60. Procedures for affixing electrodes
were performed as previously described.14 Four burr holes were
made, and electrodes were positioned and fastened (left and right
parietal, 1 cerebellar, and 1 reference posteriorly over the sinus
cavity) using mounting screws (E363/20; PlasticsOne, Roanoke,
VA). The sockets were fitted into a 6-pin electrode pedestal, and
the entire apparatus was secured with dental cement (Stoelting,
Wood Dale, IL). One week after surgery, animals were moni-
tored continuously for 3 to 14 days by video-EEG recording
(Natus, Middleton, WI). Recordings were sampled at 4,056Hz
and were analyzed offline with concurrent video. Seizures and
epileptiform activity were assessed manually in their entirety by
fellowship-trained and board-certified epileptologists blind to
experiments. IEDs are described as transients distinguishable
from background activity with a characteristic morphology, typi-
cally but neither exclusively nor invariably found in interictal
EEGs of people with epilepsy. Epileptiform patterns have to ful-
fill at least 4 of the following 6 criteria: (1) di- or triphasic waves
with sharp wave or spike morphology (<200-millisecond dura-
tion); (2) different wave duration than the ongoing background
activity; (3) asymmetry of the waveform, a sharply rising ascend-
ing phase and a more slowly descending phase, or vice versa;
(4) transient is followed by an associated after-going slow wave;
(5) background activity surrounding epileptiform discharges is
disrupted by the presence of the epileptiform discharges; and
(6) distribution of the negative and positive potentials on the
scalp suggests a source of the signal in the brain.15 Seizures are
defined as EEG phenomenon consisting of repetitive epilepti-
form EEG discharges at >2 cycles/s and/or characteristic pattern
with quasi-rhythmic spatiotemporal evolution (ie, gradual change
in frequency, amplitude, morphology, and location), lasting at
least several seconds (usually > 10 seconds). Two other short
duration (<10 seconds) EEG seizure patterns are defined as elec-
trodecrement or LVFA seen during clinically apparent epileptic
seizures. EEG seizure patterns unaccompanied by behavioral epi-
leptic manifestations are referred to as electrographic or subclini-
cal seizures.15 For detection of sleep state, EEG voltage data were
converted into a time-frequency power graph using a multitaper
FIGURE 1: Depdc5 clustered regularly interspaced short palindromic repeats (CRISPR)–in utero electroporation (IUE) leads to focal
cortical mTOR hyperactivation. (A) Two short guide RNAs (gRNAs) are used to target rat Depdc5 either at exon 8 or exon 12.
(B) CRISPR-IUE experiments are performed at embryonic day (E) 13 to E14. Animals are euthanized at postnatal day (P) 21 days for
pathology evaluation or are treated with everolimus for 11 days beginning at P10. Video-electroencephalographic (EEG) monitoring
starts at P60. (C, D) Coelectroporation of pCAG–green fluorescent protein (GFP) andDepdc5 CRISPR significantly increases pS6 immu-
noreactivity in both GFP-positive and GFP-negative cells. Stars indicate cell non-autonomous mTOR hyperactivation in the overlying
(C) and adjacent cortices (D). To show that increased pS6 in GFP-negative cells is not due to dilution of episomal GFP transfection by
dividing cells, Depdc5 CRISPR was coelectroporated with a piggyBac transposon system encoding GFP (see Materials and Methods)
that integrates into the genome of neural progenitors. (E) In control CRISPR-transfected brains, baseline pS6 immunoreactivity is mini-
mal. (F) In Depdc5 CRISPR-transfected brains, pS6 expression still markedly increases in both GFP-positive and GFP-negative cells. (E0)
Higher magnification images of E. GFP-labeled glial cells (arrows) suggest successful genome integration of GFP plasmid. (F0) Higher
magnification images of F. Many GFP-negative cells show strong pS6 immunoreactivity (arrowheads), suggesting cell non-
autonomous mTOR hyperactivation. (G) Because plasmid cotransfection efficiency is not 100%, GFP−/pS6+ neurons could be neurons
transfected with only Depdc5 CRISPR plasmid. To ensure that all neurons undergoing Depdc5 CRISPR deletion are labeled with GFP,
we electroporated a single vector plasmid that encodes eCAS9, Depdc5 gRNA, and GFP. With this approach, increased pS6 is still
observed in GFP-negative cells (arrowheads), indicating cell non-autonomous mTOR hyperactivation. (H) An antibody to a nonpho-
sphorylated neurofilament protein (SMI32) reveals aberrant cytoplasmic accumulation in both GFP-positive (arrows) and GFP-negative
neurons (arrowheads). (I) Positive filamentous nestin staining (arrows), a typical pattern in reactive astrocytes, is seen in the dysplastic
cortex. However, balloon cells, a pathological hallmark of focal cortical dysplasia IIB, which show patchy and accumulated nestin stain-
ing in the cell body, are never seen in Depdc5 CRISPR–transfected brains. Arrowhead indicates that a hypertrophic GFP-positive cell is
negative for nestin staining. (J) The soma size of Depdc5 CRISPR-transfected neurons (N = 3 rats, n = 412 cells) is nearly doubled ver-
sus control cells (N = 3, n = 715). ***Two-tailed t test, p = 0.002. (K) Postnatal administration of everolimus partially rescues cytome-
galic neurons. Drug group: N = 3, n = 661; no-drug vehicle group: N = 3, n = 1,096. ***Two-tailed t test, p = 0.005. (L, M) All cortical
neurons with Depdc5 deletion fire initial doublet action potentials (none in control), suggesting increased intrinsic excitability (L), and
show decreased input resistance (M). N = 3 rats. ***Two-tail t test, p < 0.05. Scale bar = 100 μm. CTX = cortex; WM = white matter.
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method at 1-second resolution. Each second was automatically
classified into non–rapid eye movement or wakelike states based
on bimodality tests of cortical signals as previously described.16
Please see code in SleepScoreMaster.m file in the GitHub reposi-
tory at https://github.com/buzsakilab/buzcode.
Immunocytochemistry
Brains were removed and fixed in 4% paraformaldehyde in
phosphate-buffered saline after transcardial perfusion, sectioned
at 50 to 80 μm on a vibratome (VT1000S; Leica, Wetzlar, Ger-
many), and processed for immunocytochemistry as free-floating
sections.12 Primary antibodies included mouse anti-pS6
(1:2,000, #2211; Cell Signaling Technology, Danvers, MA),
chicken anti-GFP (1: 1,000, GFP-1020; Aves Labs, Tigard,
OR), mouse antinestin (1:20, clone rat-401; Millipore, Billerica,
MA), mouse anti–nonphosphorylated neurofilament H (1:
200, clone #SMI32; BioLegend, San Diego, CA). Fluorescently
conjugated secondary antibodies (Alexa Fluor 488, 594, or 647)
were obtained from Molecular Probes (Eugene, OR), and nuclei
were labeled with Bisbenzimide (H1398, Molecular Probes).
Brain Slice Preparation, Electrophysiological
Recordings, and Data Analysis
Male and female rats (P21–P28) that previously underwent IUE
at E13 were used for electrophysiological recordings. Slices were
prepared as previously described.12 Electrophysiological record-
ings were made in a recording chamber mounted on the stage of
an upright microscope (customized Scientifica [Uckfield, UK]
optical platform). Slices were continuously perfused (miniplus 3;
Gilson, Middleton, WI) with artificial cerebrospinal fluid con-
taining 1 μM tetrodotoxin, 20 μM 6-cyano-7-nitroquinoxaline-
2,3-dione, and 20 μM d(−)2-amino-5-phosphonovaleric acid to
block action potential firing and ionotropic glutamate currents at
a rate of 5 to 6ml/min at 31–32C (in-line heater TC-324B;
Warner Instruments, Hamden, CT). GFP-expressing cells in cor-
tical layers 2 and 3 were targeted for recordings. Resistance
micropipettes (3–5MΩ) were filled with an internal solution
containing (in mM) 100 Cs-gluconate, 0.2 ethyleneglycoltetraa-
cetic acid, 5 MgCl2, 40 hydroxyethylpiperazine ethane sulfonic
acid, 2 Mg-ATP, 0.3 Na-GTP, 1 QX-314, pH 7.2. Data were
acquired at 20kHz and filtered at 5kHz. Only cells with stable
passive properties were further analyzed. We collected data from
a maximum of 3 neurons per animal to avoid bias. Statistical
analysis was performed using Prism (GraphPad Software, La
Jolla, CA). Average values for each of the variables were calcu-
lated per cell and further averaged for each experimental group.
Parametric and nonparametric statistical analyses were performed
as dictated by data distribution.
Image Acquisition, Soma Size Measurements,
and Statistical Analyses
Multichannel imaging was performed using a Leica SP5 confocal
microscope. All the images were further processed with Photoshop
CS3 software (Adobe Systems, San Jose, CA). The soma size of
GFP-positive neurons from P21P30 brains were compared
between control and Depdc5 CRISPR IUE animals. Automated
measurement was performed in ImageJ. Statistical analysis was per-
formed using Excel (Microsoft, Redmond, WA) and GraphPad.
Three or more biological replicates were used for all studies. A confi-
dence interval of 95% (p < 0.05) was required for values to be
considered statistically significant. All data are presented as mean ±
standard error of the mean unless noted otherwise.
Results
Phosphorylated ribosomal protein S6 (pS6) is commonly used
as a marker of mTORC1 activity because mTORC1 activates
p70 S6 kinase 1, which phosphorylates S6.10 To examine
mTORC1 hyperactivation, immunostaining for pS6 was per-
formed on brain sections from 3-week-old rats that were coe-
lectroporated with a Depdc5 gRNA/Cas9 construct and a
GFP-encoding plasmid (Fig 1). After Depdc5 CRISPR-IUE,
pS6 immunoreactivity and soma size significantly increased in
GFP-expressing neurons as compared to control CRISPR
transfected brains. Interestingly, cell non-autonomous mTOR
hyperactivation was observed in GFP-negative neurons with
substantial extension to overlying and adjacent cortex, in line
with clinical data indicating that histological and electro-
graphic abnormalities occur beyond MRI-visualized mar-
gins.17 Antibodies to nonphosphorylated neurofilament
proteins (SMI32) revealed aberrant cytoplasmic accumulation
of neurofilament proteins in the dysplastic cortex of Depdc5
CRISPR-IUE rats, consistent with pathological findings
observed in human FCD II.2 However, nestin-positive cells, a
hallmark of balloon cells in human FCD IIB, were not
observed. These findings suggest that focal Depdc5 somatic
mutations in rat cortex generate human FCD IIA pathologies.
Although we did not quantify the efficiency of Depdc5
gRNAs, we and other groups have shown that IUE-CRISPR
achieves gene knockout efficiency of >80%.12,18 The specific-
ity of Depdc5 deletion was confirmed by finding similar cellu-
lar and electrographic phenotypes using gRNAs targeting
2 different Depdc5 exons. Specificity was further supported by
pharmacological rescue experiments showing that treatment
with the rapamycin analog everolimus normalized soma size.
To estimate the degree of somatic Depdc5 LoF mosaicism,
genomic DNA was extracted from the dysplastic cortex
resected under fluorescent microscope. Targeted genomic
areas flanking gRNA binding sites were PCR amplified and
sent for next generation sequencing (>70,000 reads). The rate
of Depdc5 LoF mosaicism ranged from 2.64% to  3.22
% (n = 3). Whole cell patch clamp recordings of acute corti-
cal slices showed firing of doublet spikes and decreased input
resistance in GFP-labeled cortical neurons with Depdc5
deletion.
Critically, 100% (11/11 from > 3 different litters) of
rats undergoing Depdc5 IUE-CRISPR developed frequent
focal IEDs and spontaneous seizures. IEDs were restricted
to the hemisphere with dysplastic tissue, in contrast to
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generalized discharges with current FCD models (Fig 2).
Importantly, PFA, rhythmic spikes, and periodic lateralized
epileptiform discharges (PEDs), hallmarks of human FCD
II,5 were detected in the rats as well as our FCD II patients.
High-frequency oscillations was also lateralized to the
lesional side, supporting focal epileptogenicity. IEDs were
also highly sleep-dependent. Ictally, electrographic seizure
onsets were lateralized to the lesional hemisphere, and the
common onset patterns in patients with FEs, including
focal LVFA, rhythmic spikes, background suppression, and
PEDs,6 were frequently observed (Fig 3A, C, D). These
electrographic features were similar to those seen with
intracranial ictal EEG recordings in FCD II patients and
1 patient with a pathological Depdc5 mutation (see Fig
3B). Semiologically, the clinical seizure expression in rats,
including behavioral arrest, tonic stiffening, and contralat-
eral clonic activity (Supplementary Videos 1–5), more
closely recapitulates the variability seen in human FCD
than existing models that show limited semiologies or only
GTCs.7 For example, behavioral arrest was commonly
observed in these rats, similar to human complex partial
seizures. Many seizures presented with subtle clinical/
behavioral changes, such as waking up and subtle trunk
tonic posturing. GTCs occasionally occurred late into the
seizure but never occurred at the onset.
Discussion
To our knowledge, this is the first animal model that reca-
pitulates genetics, pathology, and most importantly, electro-
clinical features of human FCD IIA. We did not observe
nestin-positive balloon cells that are typically seen in human
FCD IIB.3 Considering the striking difference in neurogen-
esis between humans and rodents, particularly the absence
of outer radial glia cells in rodents,13 it is probably not a sur-
prise that a rodent model lacks certain cytoarchitectural fea-
tures. In addition, balloon cells have been shown to be silent
electrographically.19 Genetically, germline DEPDC5 muta-
tions occur more often than all other mutations in
FE-related genes combined9 and directly inhibit MTOR
FIGURE 2: Interictal discharges highly resemble human focal cortical dysplasia (FCD). For all rat electroencephalographic (EEG)
recordings, the upper trace is from an electrode implanted in the right parietal head region and the lower trace is from the left
(see Materials and Methods). (A–D) Interictal EEG recordings from rats with Depdc5 CRISPR-IUE, including paroxysmal fast
activity (A), polyspikes (B), rhythmic spike discharges (C), and periodic lateralized epileptiform discharges (D), are lateralized to
the lesional hemisphere, and are highly similar to intracranial subdural or depth EEG recordings from patients with FCD IIa,
including one with a DEPDC5 mutation (p.Tyr281Phe; A0–D0).22 For all human intracranial recordings, shown is 1 electrode
recording that captures the most representative EEG discharges. (E, F) Other typical focal interictal epileptiform discharge (IED)
examples, including single focal spikes (E) and spikes with overriding fast activity (stars) with minimal electrical field to the
opposite hemisphere (F). (G) Rapid bilaterally synchronous-appearing IEDs are seen occasionally, but they display lateralized
onset based upon asymmetric amplitude and lead-in time (red vertical line). (H) Ripples associated with a spike are displayed with
a 70- to 250Hz frequency band. (I) Ripples that are not associated with spikes. (J) Fast ripples associated with a train of spike-
and-wave discharges are displayed with a 250- to 1,000Hz frequency band. These high-frequency oscillations are also lateralized
to the lesional hemisphere. (K) Shown is a spectrogram of oscillatory power (color) versus time (horizontal) across various fre-
quencies at each time point (vertical). IEDs, shown as purple lines in the lower power spectral image, occur predominantly in
non–rapid eye movement sleep, recognized by increased lower frequency band power and lower motion scores. See upper
panel for fully visible spectrogram and see Materials and Methods. To quantify IEDs during sleep versus wakefulness, IEDs were
counted during 1 hour of sleep and wakefulness for 3 days from 3 rats with Depdc5 CRISPR-IUE. The average number of IEDs is
32.89 ± 6.326 during sleep and 7 ± 3 during wakefulness (2-tailed t test, p = 0.002).
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independently of TSC1/TSC2.10 Although DEPDC5
somatic mutations have been associated with brain malfor-
mations from FCD to hemimegalencephaly,9 how a germ-
line mutation sustains a focal pattern in inherited epilepsies
still remains enigmatic. A plausible emerging hypothesis is
that DEPDC5 germline LoF mutation together with a sec-
ond biallelic somatic hit in DEPDC5 itself leads to the
development of FCD, known as “2-hit”mechanism, initially
described in cancer and tuberous sclerosis.9 This biallelic
inactivation hypothesis is also supported by a recent report
of a DEPDC5 somatic nonsense variant in resected brain tis-
sue from an individual with FCD IIA and a familial history
of FEs due to a germline mutation in DEPDC5.9 Pathologi-
cally, both cell-autonomous and cell non-autonomous
FIGURE 3: Electroclinical seizures highly resemble human focal cortical dysplasia (FCD). (A) Shown is an entire seizure from a rat
with Depdc5 CRISPR-IUE. The top electroencephalographic (EEG) traces have a compressed time base of 5mm/s, and the lower
ones have a standard time base of 30mm/s. The seizure starts with low-voltage fast activity (LVFA; stars) followed by 2-3 Hz spike
and wave discharges (arrowheads). (B) Intracranial recordings from patients with FCD II show common ictal onset patterns includ-
ing LVFA, background suppression, and bursts of rhythmic spikes. (C, D) Two additional representative seizures recorded from rats
with Depec5 CRISRP-IUE show typical seizure onset patterns of rhythmic spikes (C) and background attenuation (D). (E–H) Thirty-
nine seizures from 3 different animals were analyzed for seizure duration (E; 35.97 ± 22.85 seconds, median = 26 seconds), fre-
quency (F; 13 ± 2.5/24 hours), EEG onset patterns (G), and semiology (H). The majority of seizures start with rhythmic spike dis-
charges (RSW; 53.8%), background suppression (25.0%), and LVFA (21.2%). Behaviorally, most seizures show clonus/myoclonus
(30.1%) or behavioral arrest (eg, freezing, stopping exploration; 23.1%). Other types include tonic posturing (12.8%) and arousal
without other clear clinical signs (15.1%); 15.1% of electrographic seizures were subclinical. Notably, only 1 seizure progressed to
a generalized tonic-clonic seizure (GTC). (I) Representative reconstructed brain sections show the size and position of Depdc5
CRISPR transfection (each black dot is a transfected neuron) at 5 rostrocaudal levels in 5 rats after EEG recording was completed
at postnatal days 70 to 90. Arrowheads indicate the section in each series with the most extensive Depdc5 CRISPR transfection.
July 2018 145
Hu et al: Somatic Depdc5 deletion
mTOR hyperactivation was observed in our model, in line
with the clinical observation that FCD histologic and elec-
trographic abnormality occurs beyond the MRI margin.17
Clinically, our Depdc5 CRISPR-IUE rats have a distinctly
different electroclinical repertoire from current FCD models.
The full spectrum of seizure semiologies and characteristic
interictal and ictal discharges are unique and highly clinically
relevant to human FCD. However, 2 important questions
remain to be answered. First, cell non-autonomous mTOR
hyperactivation, a surprising finding, likely plays an impor-
tant role in epileptogenesis and overall clinical manifesta-
tions. However, the mechanism is completely unknown.
Second, interneurons are firmly tied to ictogenesis and epi-
leptogenesis in FCD.20 However, they are born in the ven-
tral medial ganglionic eminence and lateral ganglionic
eminence,21 which are not transfected by Depdc5 CRISPR-
IUE. A unifying hypothesis would be that cell non-
autonomous mTOR hyperactivation impairs interneuron
development. Our model should pave the way to study epi-
leptogenesis and ictogenesis at cellular and circuit levels, as
well as to develop mechanistic-based therapies.
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